Dyne Therapeutics Stock (NASDAQ: DYN) stock price, news, charts, stock research, profile.
Open | $45.49 |
Close | $46.09 |
Volume / Avg. | 613.34K / 1.04M |
Day Range | $44.80 - $46.26 |
52 Wk Range | 6.40 - 47.45 |
Market Cap | $4.63B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 8.75% |
Days to Cover | 7.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.
Other companies in Dyne Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and Alkermes (NASDAQ:ALKS).
Dyne Therapeutics has a consensus price target of $50.60.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $46.09 last updated August 30, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Dyne Therapeutics.
Dyne Therapeutics’s Q3 earnings are confirmed for Monday, October 28, 2024.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.